Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Gastroenterol Hepatol ; 29(4): 240-3, 2006 Apr.
Artículo en Español | MEDLINE | ID: mdl-16584695

RESUMEN

Jaundice in Hodgkin's disease occurs in 3-13% of the cases reported in the medical literature and can be due to several causes. Cholestatic jaundice associated with ductopenia may be a consequence of an associated paraneoplastic process and can occur several months before the development of Hodgkin's disease. When there is a finding of jaundice of unknown etiology associated with ductopenia, the possible existence of Hodgkin's disease should be investigated. We describe a case of cholestatic jaundice associated with Hodgkin's disease. The first clinical and laboratory manifestations were symptoms of bloody diarrhea months before the development of Hodgkin's disease. We discuss the differential diagnoses considered, given the complexity of the case.


Asunto(s)
Colestasis/etiología , Diarrea/etiología , Hemorragia Gastrointestinal/etiología , Enfermedad de Hodgkin/complicaciones , Adulto , Humanos , Masculino
3.
Rev Calid Asist ; 31(4): 220-6, 2016.
Artículo en Español | MEDLINE | ID: mdl-26705912

RESUMEN

OBJECTIVES: To determine the mean stay (MS) of patients with pulmonary embolism (PE) in a thrombosis unit (TU) with a short stay unit (SSU) in a tertiary hospital. To compare the data collected with those of other hospitals in the same region, of other regions (Autonomous Communities [AACC]), and within the same hospital in the year before the SSU opened. MATERIAL AND METHODS: A descriptive retrospective observational study that included patients with a diagnosis of PE in the University Hospital Virgen de la Arrixaca (HCUVA) in 2012. These data were classified by hospital department, and used for calculating the mean stay. This was then compared with that of other hospitals in our region, with the rest of the regions, and with the data in 2007 (the last year without a TU). RESULTS: A total of 113patients with PE were included, 60 (53%) in the TU with an MS of 4.39, in Oncology, 7.45, and Internal Medicine (IM), 15.38days. There were no deaths in the TU and only 3 (5%) readmissions. Published data showed that the MS in all hospitals in our region was 8.25, 5.18 in our hospital, and higher in the rest of hospitals. The best AACC was the Basque Country with an MS of 6.85days. In 2007, there were 70patients with PE in the HCUVA, 34 (49%) in IM, with an MS of 8.50, Oncology 11 (31%) with an MS 9.64, and Chest Diseases 3 (4.3%) with an MS 19days, and with an overall mortality of 11% and a rate of readmissions in IM of 6%. CONCLUSION: The mean stay for a PE in the SSU of a TU was lower than in the rest of the hospital departments, lower than the rest hospitals of our region, lower than the rest of the regions, and lower than any department of our hospital before the SSU existed, without increasing the readmission or mortality rate.


Asunto(s)
Embolia Pulmonar/terapia , Centros de Atención Terciaria , Humanos , Tiempo de Internación , Embolia Pulmonar/diagnóstico , Estudios Retrospectivos , España
4.
J Sports Med Phys Fitness ; 55(11): 1371-5, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25303168

RESUMEN

AIM: The aim of this paper was to highlight the special frequency of cases of rhabdomyolysis related to the practice of indoor cycling and to define the characteristics, course, and outcome of this disease. METHODS: Retrospective review of clinical histories of patients diagnosed with rhabdomyolysis after indoor cycling in our unit from January 2012 to April 2013. RESULTS: Eleven patients were analyzed. All patients, regardless of the degree of previous physical training, were diagnosed after a first session of indoor cycling. Mean age was 27.63 years (SD=5.74). Fifty-four percent were women. Creatine kinase (CK) levels gradually decreased in response to rest and intensive intravenous hydration. Only in two cases was renal failure observed, and in none were electrolyte disorders, disseminated intravascular coagulation (DIC) or compartmental syndrome detected. CONCLUSION: A first session of indoor cycling has become a common cause of rhabdomyolysis secondary to the physical exercise in recent years, which should alert those responsible for teaching this sport of the need for a gradual start under adequate hydration and environmental conditions, because although the condition has a benign course with adequate treatment and the complication rate is low, there are patients with increased susceptibility to very high CK blood levels requiring hospitalization for treatment and follow-up of possible complications.


Asunto(s)
Creatina Quinasa/sangre , Terapia por Ejercicio/métodos , Ejercicio Físico/fisiología , Rabdomiólisis/rehabilitación , Adolescente , Adulto , Femenino , Humanos , Masculino , Estudios Retrospectivos , Rabdomiólisis/sangre , Adulto Joven
5.
Histol Histopathol ; 18(4): 1027-33, 2003 10.
Artículo en Inglés | MEDLINE | ID: mdl-12973671

RESUMEN

Calcium appears to be involved in many of the cellular events which are thought to be important in atherogenesis. Calcium channel blockers have been shown to reduce arterial lipid accumulation in animals without altering serum cholesterol. Avian models of atherosclerosis offer economic and technical advantages over mammalian models. In this study, we examine the effects of nifedipine, verapamil and diltiazem at clinical and higher doses, on the extent of atherosclerosis of egg-fed chickens. In order to assess the extent of atherosclerosis quantitatively, the aortic lesions of the thoracic and abdominal aorta, aortic arch and supraaortic regions were measured by planimetry. Atherosclerotic lesions were evaluated histologically. Statistically significant reductions in the lipid deposition of the aorta were found in all the treated groups. The extent and distribution of atherosclerotic lesions were decreased in a significant way by verapamil, nifedipine and diltiazem. The higher the dosage used, the higher the regression of the atherosclerotic lesions. At clinical dosage, nifedipine showed the highest decrease of the lesions. In addition, the chicken atherosclerosis model has proved itself useful and very suitable for in vivo drug intervention studies.


Asunto(s)
Aorta Abdominal/patología , Aorta Torácica/patología , Arteriosclerosis/tratamiento farmacológico , Arteriosclerosis/patología , Bloqueadores de los Canales de Calcio/uso terapéutico , Pollos/fisiología , Diltiazem/uso terapéutico , Nifedipino/uso terapéutico , Verapamilo/uso terapéutico , Animales , Aorta Abdominal/ultraestructura , Aorta Torácica/ultraestructura , Colesterol en la Dieta/farmacología , Colorantes , Dieta Aterogénica , Masculino , Microscopía Electrónica , Fijación del Tejido
6.
Gastroenterol Hepatol ; 27(5): 311-3, 2004 May.
Artículo en Español | MEDLINE | ID: mdl-15117610

RESUMEN

Small bowel bleeding is infrequent and presents a challenge to the clinician. Approximately 30-40% of gastrointestinal bleeding localized in the small bowel is due to angiodysplasia, a vascular malformation. We present the case of a patient with multiple angiodysplasia of the small bowel who required push enteroscopy and capsule endoscopy to establish the diagnosis. Treatment with subcutaneous octreotide was successful. In conclusion, in doubtful cases or in patients with persistent hemorrhage, capsule endoscopy can improve the diagnostic yield of enteroscopy in bleeding gastrointestinal vascular lesions such as angiodysplasia. Endoscopic treatment (laser coagulation) and drug therapy (somatostatin or analogs) are valid alternatives in inoperable or non-resectable cases.


Asunto(s)
Angiodisplasia , Intestino Delgado , Anciano , Angiodisplasia/diagnóstico , Angiodisplasia/tratamiento farmacológico , Fármacos Gastrointestinales/uso terapéutico , Humanos , Enfermedades Intestinales/diagnóstico , Enfermedades Intestinales/tratamiento farmacológico , Masculino , Octreótido/uso terapéutico
7.
An Med Interna ; 6(6): 315-7, 1989 Jun.
Artículo en Español | MEDLINE | ID: mdl-2491557

RESUMEN

The dissemination of multiple myeloma out of the bone marrow is very rare, even though the observation of plasmacytosis in the bodies of patients having died of this disease is not rare. We present 2 patients affected by multiple myeloma and with extra-bone marrow plasmacytomas at the diagnosis, localized at posterior mediastinum and retroperitoneum, discovered by tomography.


Asunto(s)
Mieloma Múltiple/patología , Neoplasias Retroperitoneales/secundario , Neoplasias Torácicas/secundario , Humanos , Masculino , Persona de Mediana Edad , Mieloma Múltiple/diagnóstico por imagen , Invasividad Neoplásica , Neoplasias Retroperitoneales/diagnóstico por imagen , Costillas/patología , Neoplasias Torácicas/diagnóstico por imagen , Vértebras Torácicas/patología , Tomografía Computarizada por Rayos X
8.
An Med Interna ; 18(3): 136-8, 2001 Mar.
Artículo en Español | MEDLINE | ID: mdl-11594178

RESUMEN

Myophosphorylase deficiency, or McArdle disease, is an uncommon entity. The gene for human myophosphorylase has been cloned and is located on chromosome 11, in keeping with the autosomal recessive nature of the disease and there is an excess of male patients. The diagnosis is established by documentation of elevated glycogen content and reduced phosphorylase activity in biopsied muscle tissue. We report four cases with McArdle disease which were 16, 15, 11 and 5 years old. They were brothers, and they came to the hospital because of pain, cramps and myoglobinuria after exercise or infection; in the first case, a male patient, myoglobinuria caused acute renal failure. Three of them showed reduced phosphorylase activity in biopsied muscle tissue. We discuss the different therapeutic possibilities.


Asunto(s)
Enfermedad del Almacenamiento de Glucógeno Tipo V/diagnóstico , Enfermedad del Almacenamiento de Glucógeno Tipo V/genética , Adolescente , Niño , Enfermedad del Almacenamiento de Glucógeno Tipo V/enzimología , Humanos , Masculino , Fosforilasas/deficiencia
10.
Rev. calid. asist ; 31(4): 220-226, jul.-ago. 2016. graf, tab
Artículo en Español | IBECS (España) | ID: ibc-153997

RESUMEN

Objetivo. Describir la estancia media (EM) de la embolia de pulmón (EP) en una unidad de trombosis (UT) dependiente de una unidad de corta estancia (UCE) de un hospital de tercer nivel. Comparar estos datos con el resto de hospitales de nuestra región, con los del resto de comunidades autónomas (CCAA) y con el mismo hospital durante un año previo a nuestra existencia. Material y método. Estudio observacional retrospectivo descriptivo en el que se incluyeron los pacientes con diagnóstico de EP en el Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA) durante el año 2012. Clasificamos estos datos por servicio hospitalario, calculando la EM. Comparamos esta con la del resto de hospitales de nuestra región, con el resto de CCAA y con nuestros datos en el año 2007, cuando no existía aun la UT. Resultados. Se incluyeron 113 pacientes: 60 (53%) ingresaron en la UT, siendo la EM de 4,39 días, en Oncología, de 7,45, y en Medicina Interna (MI), de 15,38. No hubo ningún fallecido en la UT y solo se produjeron 3 reingresos (5%). Los datos publicados mostraron que la EM en todos los hospitales de nuestra región fue de 8,25 días; en nuestro hospital fue de 5,18 días y en el resto de hospitales, mayor. La CCAA con mejor EM fue el País Vasco con 6,85 días. En el año 2007, hubo 70 pacientes con EP en el HCUVA: 34 (49%) en MI con una EM de 8,50 días, 11 (31%) en Oncología con una EM de 9,64 días y 3 (4,3%) en Neumología, con una EM de 19 días; la mortalidad global fue del 11% y la tasa de reingresos en MI, del 6%. Conclusión. La EM de la EP en la UT en una UCE fue menor que en el resto de servicios de nuestro hospital, menor que en el resto de hospitales de nuestra comunidad, menor que en el resto de CCAA y menor que en cualquier servicio de nuestro hospital en una época anterior a nuestra existencia, sin aumentar la tasa de reingreso ni la mortalidad (AU)


Objectives. To determine the mean stay (MS) of patients with pulmonary embolism (PE) in a thrombosis unit (TU) with a short stay unit (SSU) in a tertiary hospital. To compare the data collected with those of other hospitals in the same region, of other regions (Autonomous Communities [AACC]), and within the same hospital in the year before the SSU opened. Material and methods. A descriptive retrospective observational study that included patients with a diagnosis of PE in the University Hospital Virgen de la Arrixaca (HCUVA) in 2012. These data were classified by hospital department, and used for calculating the mean stay. This was then compared with that of other hospitals in our region, with the rest of the regions, and with the data in 2007 (the last year without a TU). Results. A total of 113 patients with PE were included, 60 (53%) in the TU with an MS of 4.39, in Oncology, 7.45, and Internal Medicine (IM), 15.38 days. There were no deaths in the TU and only 3 (5%) readmissions. Published data showed that the MS in all hospitals in our region was 8.25, 5.18 in our hospital, and higher in the rest of hospitals. The best AACC was the Basque Country with an MS of 6.85 days. In 2007, there were 70 patients with PE in the HCUVA, 34 (49%) in IM, with an MS of 8.50, Oncology 11 (31%) with an MS 9.64, and Chest Diseases 3 (4.3%) with an MS 19 days, and with an overall mortality of 11% and a rate of readmissions in IM of 6%. Conclusion. The mean stay for a PE in the SSU of a TU was lower than in the rest of the hospital departments, lower than the rest hospitals of our region, lower than the rest of the regions, and lower than any department of our hospital before the SSU existed, without increasing the readmission or mortality rate (AU)


Asunto(s)
Humanos , Masculino , Femenino , Embolia Pulmonar/epidemiología , Embolia Pulmonar/prevención & control , Embolia Pulmonar/terapia , Tiempo de Internación/economía , Trombosis/complicaciones , Trombosis/terapia , Estudios Retrospectivos , Hospitalización/economía , Hospitalización/estadística & datos numéricos , Demografía/clasificación
16.
Histol Histopathol ; 23(9): 1131-42, 2008 09.
Artículo en Inglés | MEDLINE | ID: mdl-18581284

RESUMEN

Complex interrelationships exist between hyperlipidemia and the progression of renal injury. The aim of this study was to evaluate the impact of high plasma cholesterol and triglyceride levels on renal structure and the effects of atorvastatin on progression-regression of renal injury. One-hundred chickens were divided into five groups: Group A: Standard diet (SD) for 6 months; Group B: Hyperlipidemic diet (HD) for 6 months; Group C: HD for three months and SD during the next 3 months; Group D: HD for 3 months and SD during the next 3 months, when they received oral atorvastatin (3 mg/kg/d); Group E: HD for the whole 6 months, and atorvastatin (3 mg/kg/d) during the last 3 months. Increased alpha-actine immunostaining was found in glomeruli of groups B and C. An important decrease of immunostaining was observed in glomeruli of atorvastatin treated groups. Group D showed the lowest value for presence of lipids, and significant differences were found with respect to the rest of the groups. The glomeruli of group B presented the highest damage grades and those of group D showed the lowest grades and presented significant differences from the rest of the groups. The combination of atorvastatin therapy and proper diet proved to be effective in promoting renal disease regression. However, the study of several parameters indicates that neither only diet nor atorvastatin in the progression group resulted completely effective in decreasing the progression of the disease.


Asunto(s)
Anticolesterolemiantes/uso terapéutico , Ácidos Heptanoicos/uso terapéutico , Hiperlipidemias/tratamiento farmacológico , Enfermedades Renales/tratamiento farmacológico , Pirroles/uso terapéutico , Animales , Atorvastatina , Pollos , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Esquema de Medicación , Hiperlipidemias/complicaciones , Hiperlipidemias/patología , Enfermedades Renales/etiología , Enfermedades Renales/patología , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/metabolismo , Glomérulos Renales/ultraestructura , Túbulos Renales/efectos de los fármacos , Túbulos Renales/metabolismo , Túbulos Renales/ultraestructura , Lípidos/sangre , Masculino
18.
An. vet. Murcia ; 27: 119-128, ene.-dic. 2011. tab, ilus
Artículo en Español | IBECS (España) | ID: ibc-106595

RESUMEN

La enfermedad cardiovascular es hoy en día la primera causa de mortalidad en las sociedades desarrolladas. Dada la complejidad del desarrollo de la lesión aterosclerótica en el ser humano resulta interesante investigar en modelos animales en los que dicho proceso sea semejante a la enfermedad humana. El pollo, al igual que otras aves, es capaz de desarrollar arteriosclerosis aórtica y coronaria de forma natural o espontánea, e inducida por una dieta enriquecida en colesterol. Teniendo en cuenta que la mayoría de los trabajos publicados describen las lesiones en segmentos aórticos y la variedad de métodos de inducción de la arteriosclerosis, el objetivo de esta investigación es caracterizar de manera adecuada en el modelo aviar utilizado, las lesiones arterioscleróticas de troncos supra-aórticos en un grupo experimental con respecto a un grupo control. Se emplearon 20 pollos de la raza White Leghorn divididos en dos grupos (control y aterogénico) que recibían una dieta normal o hiperlipémica respectivamente durante un periodo de 6 meses. Se sacrificaron entonces los animales para llevar a cabo el estudio bioquímico del plasma (perfil lipídico), evaluación histológica de los troncos supra-aórticos y valoración semicuantitativa de las lesiones según la clasificación de Stary. Se observaron diferencias estadísticamente significativas entre ambos grupos para los diferentes parámetros bioquímicos estudiados y para la cuantificación del grado de lesión de Stary. En el grupo aterogénico se observó un endotelio conservado, con íntimas muy aumentadas de tamaño (10 veces el tamaño del grupo control) y muy desorganizadas. En conclusión, estos hallazgos confirman el uso del pollo como biomodelo experimental para el estudio de la arteriosclerosis en troncos supra-aórticos, y podrían ser empleados como referencia para futuros estudios intervencionistas(AU)


Cardiovascular diseases are considered first cause of human mortality in developed countries. Animal models allow adequate research of atherosclerosis, given the similarities with the human lesions. Chickens may develop spontaneous and also induced atherosclerosis by use of a cholesterol-enriched diet. Most published findings describe aortic lesions in a variety of induction methods. Therefore, the aim of this research is to characterize the used avian model, describing supra-aortic trunk lesions in atherosclerotic chickens and to compare it with control animals. Twenty White Leghorn chickens were used (10 controls fed with a normal diet and 10 atherogenic animals fed with a hyperlipidemic diet, for 6 months). After sacrifice, lipid biochemical parameters were analysed, as well as histologic evaluation of supra-aortic vessels and quantification of lesions following the Stary classification. Statistically significant differences for each parameter were observed between the control and experimental groups. Increased intima layer width with disorganization was observed in atherogenic animals. These findings confirm the use of the chicken as an adequate experimental animal for atherosclerosis, and could be used as a reference for future interventional studies(AU)


Asunto(s)
Animales , Embrión de Pollo , Pollos , Modelos Animales , Arteriosclerosis/complicaciones , Arteriosclerosis/diagnóstico , Arteriosclerosis/terapia , Arteriosclerosis/veterinaria , Experimentación Animal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA